Showing results (141-150 of 234) with videos related to
Sort By:
Pageof 24
Journal of Medicinal Chemistry|October 16, 2013
Design, synthesis, and biological evaluation of 2-oxo-3,4-dihydropyrimido[4,5-d]pyrimidinyl derivatives as new irreversible epidermal growth factor receptor inhibitors with improved pharmacokinetic propertiesShilin Xu, Tianfeng Xu, Lianwen Zhang, et al.International Journal of Nanomedicine|September 13, 2017
EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancerYang Li, Yanhong Duo, Shiyun Bao, et al.Bioorganic & Medicinal Chemistry Letters|December 17, 2011
New thiazole carboxamides as potent inhibitors of Akt kinasesShaohua Chang, Zhang Zhang, Xiaoxi Zhuang, et al.Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 9, 2023
Hepatocyte CD36 protects mice from NASH diet-induced liver injury and fibrosis via blocking N1ICD productionYuqi Li, Linkun Zhang, Junkui Jiao, et al.ACS Medicinal Chemistry Letters|October 22, 2015
Synthesis and Evaluation of Novel Erlotinib-NSAID Conjugates as More Comprehensive Anticancer AgentsYanmei Zhang, Micky D Tortorella, Jinxi Liao, et al.Advanced Healthcare Materials|August 21, 2021
Practicable Applications of Aggregation-Induced Emission with Biomedical PerspectiveYuqing Wang, Bozhang Xia, Qianqian Huang, et al.Data in Brief|March 9, 2026
Dataset of microbial community evolution in synthetic black-clay-based soils during ecological reconstructionJin Li, Dong Xiao, María Laura Gigena, et al.Journal of Medicinal Chemistry|March 5, 2014
Identification and optimization of new dual inhibitors of B-Raf and epidermal growth factor receptor kinases for overcoming resistance against vemurafenibHuimin Cheng, Yu Chang, Lianwen Zhang, et al.Nanomedicine (London, England)|August 8, 2018
Dual targeting delivery of miR-328 by functionalized mesoporous silica nanoparticles for colorectal cancer therapyYang Li, Yanhong Duo, Peng Zhai, et al.Exploration (Beijing, China)|June 16, 2023
Brain co-delivery of first-line chemotherapy drug and epigenetic bromodomain inhibitor for multidimensional enhanced synergistic glioblastoma therapyYanjie Liu, Wendie Wang, Dongya Zhang, et al.Pageof 24